The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Insights into Connect® MM & the need for better designed clinical trials
Rafat Abonour, MD, Indiana University School of Medicine, Indianapolis, IN, discusses some of the results of the Connect® MM study (NCT01081028), highlighting the need to better design clinical trials that represent patients in the real-world. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
